SHA
LGND icon

Smith Hayes Advisers’s Ligand Pharmaceuticals LGND Stock Holding History

Smith Hayes Advisers’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,206
Closed -$202K – 306
2015
Q2 		$202K Buy
+3,206
New +$202K 0.04% 307